<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/targeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/targeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2010-11-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2010-11-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/targeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes/"},"url":"https://clinicaltree.github.io/posts/targeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes/"}</script><title>Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Targeted Molecular Imaging of Antigen OC183B2 in Ovarian Cancers Using MR Molecular Probes</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1291136400" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Nov 30, 2010 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Guangnan Quan MD</a> </em>, <em> <a href="">Xiangke Du MD PhD</a> </em>, <em> <a href="">Tianlong Huo MD</a> </em>, <em> <a href="">Xubin Li MD</a> </em>, <em> <a href="">Zhengmao Wei MD</a> </em>, <em> <a href="">Heng Cui MD PhD</a> </em>, <em> <a href="">Xiaohong Chang MD</a> </em>, <em> <a href="">Yexia Cheng MD</a> </em>, <em> <a href="">Xue Ye MD</a> </em>, <em> <a href="">Hongyan Cheng MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1718 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This study was designed to develop a novel magnetic resonance (MR) probe for the antigen OC183B2 in ovarian cancer cells and investigate its imaging features in vitro and in vivo.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Molecular probes were achieved through ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) conjugated to ovarian cancer monoclonal antibodies 183B2 (OCMab183B2) using a chemical method. In the control group, USPIOs were coupled with murine immunoglobulin G (mIgG) and conjugated the same way. Native polyacrylamide gel electrophoresis was used to evaluate the conjugation reaction. The cytotoxicity of the probe was measured using the methyl thiazolyl tetrazolium assay, and its cell-labeling efficiency was evaluated by Prussian blue staining. In vitro cell MR imaging was performed to evaluate the targeting of the probe to the cells. After that, the OCMab183B2 USPIOs and mIgG USPIOs were injected intravenously into nude mice implanted with ovarian cancer xenograft tumors, respectively. T2-weighted imaging and T2 mapping were then performed on a 3.0-T MR imaging system equipped with an animal birdcage coil at different times. Finally, the nude mice were sacrificed for histologic examination to confirm the imaging results.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Native polyacrylamide gel electrophoresis displayed an optimal conjugation of USPIOs to OCMab183B2 and mIgG. Various blue-staining particles were found in the cells labeled with the molecular probe at different iron concentrations, and the density of particles was positively related to the iron concentration. Its labeling rate was 96.06%, which was higher than that of USPIOs (62.5%) at the same iron concentration (20 μg/mL). The methyl thiazolyl tetrazolium assay showed that there was no difference in cellular bioactivity between OCMab183B2 USPIO–labeled and nonlabeled cells ( <em>P</em> &gt; .05). In vitro cell MR imaging showed that there was an obvious decrease in signal intensity for the probe-labeled cells compared to mIgG USPIO–labeled cells. For in vivo MR imaging, distinct changes of signal intensities and T2 values of ovarian cancers were detected after the injection of OCMab183B2 USPIOs compared to mIgG USPIOs. The histologic analysis showed that iron depositions were visualized in the experimental group but not in the control group.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>OCMab183B2 USPIO conjugates have the potential to be useful as OC183B2-targeted MR imaging agents for the early detection of ovarian cancers.</p><p>Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynecologic malignancies. Early detection and accurate diagnosis are crucial for its successful treatment . Magnetic resonance (MR) imaging has emerged as an important contributor to its diagnosis, but current conventional MR imaging has several limitations in early diagnosis due to its imaging mechanism, which is based on anatomic changes . Recent developments in molecular imaging have provided new views for cancer imaging and treatment. This new imaging technology focuses on molecular changes of diseases and enables MR imaging to detect these changes at “predisease states.” In the process of MR molecular imaging, an important step is to develop a targeted imaging probe, which is made of MR contrast agents, mostly including superparamagnetic iron oxide nanoparticles or ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs), and various ligands or antibodies. This imaging strategy relies on targeted imaging of biomarker molecules coupled with imaging probes guided by ligands or antibodies that can recognize and interact with target molecules .</p><p>In our previous studies, we have discovered an ovarian cancer antigen 183B2 (OC183B2), which is expressed on both cytoplasm and cytomembrane of SKOV-3 cells, one kind of epithelial ovarian carcinoma cells, and we successfully obtained its monoclonal antibody (OCMab183B2) from mouse ascites . The murine monoclonal antibody OCMab183B2 was raised against human epithelial ovarian adenocarcinoma-associated antigen by the fusion of murine myeloma cells with spleen lymphocytes from BALB/c nude mice immunized with soluble antigens prepared from ovarian papillary serous cyst adenocarcinoma. The monoclonal antibody was stable after culture, and its subclass was immunoglobulin G. In the current study, we aimed to develop novel MR molecular probe OCMab183B2 USPIO targeting to the antigen OC183B2 and then investigate its imaging features in vitro and in vivo.</p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="cell-culture"><span class="mr-2">Cell Culture</span><a href="#cell-culture" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="immunocytochemistry"><span class="mr-2">Immunocytochemistry</span><a href="#immunocytochemistry" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conjugation-of-antibody-with-biocompatible-magnetic-nanoparticles"><span class="mr-2">Conjugation of Antibody with Biocompatible Magnetic Nanoparticles</span><a href="#conjugation-of-antibody-with-biocompatible-magnetic-nanoparticles" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="native-polyacrylamide-gel-electrophoresis"><span class="mr-2">Native Polyacrylamide Gel Electrophoresis</span><a href="#native-polyacrylamide-gel-electrophoresis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="labeling-of-oc183b2-uspios-and-uspios"><span class="mr-2">Labeling of OC183B2 USPIOs and USPIOs</span><a href="#labeling-of-oc183b2-uspios-and-uspios" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="methyl-thiazolyl-tetrazolium-mtt-assay"><span class="mr-2">Methyl Thiazolyl Tetrazolium (MTT) Assay</span><a href="#methyl-thiazolyl-tetrazolium-mtt-assay" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="in-vitro-mr-imaging"><span class="mr-2">In Vitro MR Imaging</span><a href="#in-vitro-mr-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="animals-and-tumor-models"><span class="mr-2">Animals and Tumor Models</span><a href="#animals-and-tumor-models" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="in-vivo-mr-imaging"><span class="mr-2">In Vivo MR Imaging</span><a href="#in-vivo-mr-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="cell-culture-1"><span class="mr-2">Cell Culture</span><a href="#cell-culture-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="expression-of-the-antigen-oc183b2-in-skov-3-cells"><span class="mr-2">Expression of the Antigen OC183B2 in SKOV-3 Cells</span><a href="#expression-of-the-antigen-oc183b2-in-skov-3-cells" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/0_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/0_1s20S1076633210004083.jpg" alt="Figure 1, The OC183B2 tumor antigen was detected by immunocytochemical staining of ovarian carcinoma SKOV-3 cells with monoclonal antibody directed to OC183B2. (a) Tumor cells demonstrated positive staining for antigen OC183B2 on cell surface membrane as well as cytoplasm (Streptavidin- perosidase (SP); magnification, 400×). (b) Negative control was the staining of tumor cells with secondary antibody but without primary monoclonal antibody (SP; magnification, 400×)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="native-polyacrylamide-gel-electrophoresis-1"><span class="mr-2">Native Polyacrylamide Gel Electrophoresis</span><a href="#native-polyacrylamide-gel-electrophoresis-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/1_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/1_1s20S1076633210004083.jpg" alt="Figure 2, The gel stained by Coomassie blue after electrophoresis. Lanes A, B, C, and D were filled with OCMab183B2 ultrasmall superparamagnetic iron oxide nanoparticle (USPIO) conjugates, a mixture of USPIOs and OCMab183B2, USPIO nanocrystals, and OCMab183B2, respectively. There was no difference between lanes B and D but a remarkable difference between lanes A and D." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="comparing-the-labeling-ability-between-oc183b2-uspios-and-uspios"><span class="mr-2">Comparing the Labeling Ability Between OC183B2 USPIOs and USPIOs</span><a href="#comparing-the-labeling-ability-between-oc183b2-uspios-and-uspios" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/2_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/2_1s20S1076633210004083.jpg" alt="Figure 3, Prussian blue staining of labeled cells with different iron concentration of probes and ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) (magnification, 100×). (a) Probe at an iron concentration of 40 μg/mL. (b) Probe at an iron concentration of 20 μg/mL. (c) USPIOs at an iron concentration of 20 μg/mL. (d) Blank control." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mtt-results"><span class="mr-2">MTT Results</span><a href="#mtt-results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/3_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/3_1s20S1076633210004083.jpg" alt="Figure 4, Methyl thiazolyl tetrazolium (MTT) assay of labeled cells with OCMab183B2 ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) at different iron concentrations. There was no significant difference of optical density (OD) values between labeled and unlabeled cells, demonstrating that OCMab183B2 USPIOs are safe to the SKOV-3 cells." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="in-vitro-mr-imaging-1"><span class="mr-2">In Vitro MR Imaging</span><a href="#in-vitro-mr-imaging-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/4_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/4_1s20S1076633210004083.jpg" alt="Figure 5, In vitro T2-weighted magnetic resonance imaging of SKOV-3 cells. (a) Unlabelled cells. (b) Labeled cells with ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs). (c) Labeled cells with murine immunoglobulin G USPIOs. (d) Labeled cells with OCMab183B2 USPIOs. Cells cultured with OCMab183B2 USPIOs showed much lower T2 signal intensity than other cells." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="in-vivo-mr-imaging-1"><span class="mr-2">In Vivo MR Imaging</span><a href="#in-vivo-mr-imaging-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/5_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/5_1s20S1076633210004083.jpg" alt="Figure 6, T2-weighted imaging of the tumor at different times after the injection of OCMab183B2 ultrasmall superparamagnetic iron oxide nanoparticle (USPIO) conjugates. The signal intensity of the tumor slowly decreased from 5 minutes to 4 hours and did not change remarkably from 4 to 12 hours after injection. The signal intensity reached the minimum point 24 hours after injection and then began to increase. Forty-eight hours after injection, there was no remarkable difference compared to the initial state." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/6_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/6_1s20S1076633210004083.jpg" alt="Figure 7, The changes of T2 values of the tumors after the injection of OCMab183B2 ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) and murine immunoglobulin G (mIgG) USPIOs. A different trend existed in both groups. For OCMab183B2 USPIOs, the T2 value slowly decreased and reached the minimum 48 hours after injection. For mIgG USPIOs, the value first decreased from 5 minutes to 4 hours and then began to increase until 48 hours after injection. The T2 values of tumors at 24 hours after injection in the experimental and control groups indicated a significant difference." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/7_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/7_1s20S1076633210004083.jpg" alt="Figure 8, T2-weighted imaging of the tumor at different times after the injection of murine immunoglobulin G (mIgG) ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs). The signal intensity of the tumor slowly decreased from 5 minutes to 2 hours and then began to revert to its initial state after 48 hours of injection." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histologic-analysis"><span class="mr-2">Histologic Analysis</span><a href="#histologic-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/8_1s20S1076633210004083.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/TargetedMolecularImagingofAntigenOC183B2inOvarianCancersUsingMRMolecularProbes/8_1s20S1076633210004083.jpg" alt="Figure 9, Photomicrography of Prussian blue staining of tumors 48 hours after injection. Blue particles deposited in tumors after the injection of OCMab183B2 ultrasmall superparamagnetic iron oxide nanoparticles (USPIOs) (a) , while no blue particles in tumors after the injection of murine immunoglobulin G USPIOs (b) (magnification, 400×)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Young R.C., Perez C.A., Hoskins W.J.: Cancer of the ovary.DeVita V.T.Hellman S.Rosenberg S.A.Cancer: principles and practice of oncology.1993.LippincottPhiladelphia, PA:pp. 1226-1263.</p><li><p>2. Nicoletta C., Toon V.G., Gabriella P., et. al.: Ovarian cancer. Crit Rev Oncol Hematol 2006; 60: pp. 159-179.</p><li><p>3. Hanna S., Maarit A., Johanna N., et. al.: A highly reproducible xenograft model for human ovarian carcinoma and application of MRI and ultrasound in longitudinal follow-up. Gynecol Oncol 2006; 103: pp. 315-320.</p><li><p>4. Outwater E.K., Siegelman E.S., Kim B., et. al.: Ovarian Brenner tumors: MR imaging characteristics. Magn Reson Imaging 1998; 16: pp. 1147-1153.</p><li><p>5. Tanaka Y.O., Yoshizako T., Nishida M., et. al.: Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR Am J Roentgenol 2000; 175: pp. 1423-1430.</p><li><p>6. Togashi K.: Ovarian cancer: the clinical role of US, CT, and MRI. Eur Radiol 2003; 13: pp. L87-L104.</p><li><p>7. Katayama M., Masui T., Kobayashi S., et. al.: Diffusion-weighted echo planar imaging of ovarian tumors: is it useful to measure apparent diffusion coefficients. J Comput Assist Tomogr 2002; 26: pp. 250-256.</p><li><p>8. Weissleder R., Mahmood U.: Molecular imaging. Radiology 2001; 219: pp. 316-333.</p><li><p>9. Weissleder R.: Molecular imaging: exploring the next frontier. Radiology 1999; 212: pp. 609-614.</p><li><p>10. Weissleder R., Pittet M.J.: Imaging in the era of molecular oncology. Nature 2008; 452: pp. 580-589.</p><li><p>11. Chaudhuri T.R., Rogers B.E., Buchsbaum D.J., et. al.: A Noninvasive reporter system to image adenoviral-mediated gene transfer to ovarian cancer xenografts. Gynecol Oncol 2001; 83: pp. 432-438.</p><li><p>12. Tiefenauer L.X., Tschirky A., Kühne G., et. al.: In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn Reson Imaging 1996; 14: pp. 391-402.</p><li><p>13. Huang G., Diakur J., Xu Z., et. al.: Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. Int J Pharm 2008; 360: pp. 197-203.</p><li><p>14. Qian H.N., Feng J., Cui H., et. al.: Generation and characterization of three monoclonal antibodies to human ovarian epithelial adenocarcinomas. Chin Med J (Engl) 1989; 102: pp. 839-843.</p><li><p>15. Li Z., Wei L., Gao M.Y., et. al.: One-pot reaction to synthesize biocompatible magnetite nanoparticles. Adv Mater 2005; 17: pp. 1001-1005.</p><li><p>16. Hu F.Q., Li Z., Tu C.F., et. al.: Preparation of magnetite nanocrystals with surface reactive moieties by one-pot reaction. J Colloid Interface Sci 2007; 311: pp. 469-474.</p><li><p>17. Hu F.Q., Li Z., Tu C.F., et. al.: Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Adv Mater 2006; 18: pp. 2553-2556.</p><li><p>18. Loyer E.M., Whiteman G.J., Fenstermacher M.J.: Imaging of ovarian carcinoma. Int J Gynecol Cancer 1999; 9: pp. 351-361.</p><li><p>19. Kuszyk B.S., Corl F.M., Franano N.F., et. al.: Tumor transport physiology: implications for imaging and imaging-guided therapy. AJR Am J Roentgenol 2001; 177: pp. 747.</p><li><p>20. Rakesh K.J.: Delivery of molecular medicine to solid tumors. Science 1996; 271: pp. 1079.</p><li><p>21. Jain R.K.: Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Rel 2001; 74: pp. 7-25.</p><li><p>22. Saccavini J.C., Curtet C., Bohy J., et. al.: Magnetic resonance imaging studies on nude mice grafted with colorectal adenocarcinoma using gadolinium-labelled monoclonal antibody. Invest Radiol 1988; 23: pp. 292-293.</p><li><p>23. Matumura A., Shibata Y., Nakagawa K., et. al.: MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats. Acta Neurchir Suppl (Wien) 1994; 60: pp. 356-358.</p><li><p>24. Toma A., Otsuji E., Kuriu Y., et. al.: Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma. Br J Cancer 2005; 93: pp. 131-136.</p><li><p>25. Yoshiaki K., Eigo O., Syuichi K., et. al.: Monoclonal antibody conjugated to gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma. J Surg Oncol 2006; 94: pp. 144-148.</p><li><p>26. Marie-France B, M Vasile, S. Morel P. Currently used non-specific extracellular MR contrast media. Eur Radiol 2003; 3:2688–2698.</p><li><p>27. Marie-France B.: MR contrast agents, the old and the new. Eur Radiol 2006; 60: pp. 314-323.</p><li><p>28. Bremer C., Ntziachristos V., Weissleder R.: Optical-based molecular imaging contrast agents and potential medical applications. Eur Radiol 2003; 13: pp. 231-243.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-17/'>Volume 17</a>, <a href='/categories/issue-12/'>Issue 12</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Targeted%20Molecular%20Imaging%20of%20Antigen%20OC183B2%20in%20Ovarian%20Cancers%20Using%20MR%20Molecular%20Probes%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ftargeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Targeted%20Molecular%20Imaging%20of%20Antigen%20OC183B2%20in%20Ovarian%20Cancers%20Using%20MR%20Molecular%20Probes%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ftargeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ftargeted-molecular-imaging-of-antigen-oc183b2-in-ovarian-cancers-using-mr-molecular-probes%2F&text=Targeted%20Molecular%20Imaging%20of%20Antigen%20OC183B2%20in%20Ovarian%20Cancers%20Using%20MR%20Molecular%20Probes%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-new-computerized-measurement-approach-of-carotid-artery-stenosis-on-tomographic-image-sequence/"><div class="card-body"> <em class="small" data-ts="1291136400" data-df="ll" > Nov 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A New Computerized Measurement Approach of Carotid Artery Stenosis on Tomographic Image Sequence</h3><div class="text-muted small"><p> Rationale and Objectives The stenosis degree of carotid artery (CA) can be a critical factor for treatment of cerebrovascular disease and for determining candidate of carotid endarterectomy. Curre...</p></div></div></a></div><div class="card"> <a href="/posts/a-text-to-speech-converter-for-radiology-journal-articles/"><div class="card-body"> <em class="small" data-ts="1291136400" data-df="ll" > Nov 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Text-to-Speech Converter for Radiology Journal Articles</h3><div class="text-muted small"><p> Radiology articles are primarily designed to be read on paper or a screen. Audio versions let users hear this material during activities when reading is not practical. Currently, there are relative...</p></div></div></a></div><div class="card"> <a href="/posts/an-interactive-web-based-tool-for-detecting-verification-work-up-bias-in-studies-of-the-efficacy-o/"><div class="card-body"> <em class="small" data-ts="1291136400" data-df="ll" > Nov 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>An Interactive Web-Based Tool for Detecting Verification (Work-up) Bias in Studies of the Efficacy of Diagnostic Imaging</h3><div class="text-muted small"><p> Rationale and Objectives Diagnostic tests are validated by comparison against a “gold standard” reference test. When the reference test is invasive or expensive, it may not be applied to all patie...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/success-breeds-success/" class="btn btn-outline-primary" prompt="Older"><p>Success Breeds Success</p></a> <a href="/posts/the-arr-s-anniversary/" class="btn btn-outline-primary" prompt="Newer"><p>The ARR’s Anniversary</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
